December 12, 2011 -- In an interview with Reuters, Pfizer executives said the company has a two-fold R&D strategy: it will keep expanding its in-house China R&D team while also seeking to collaborate with external China pharmas. Pfizer already employs about 600 researchers at its three China R&D centers in Beijing, Shanghai and Wuhan. More details....
Stock Symbol: (NYSE: PFE)
